James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 100,000 shares at $22.83 ($2.3M) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market sale of $2.3M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.83 | 27,355 | $625K | 27.1% |
| 2 | $22.83 | 27,355 | $625K | 27.1% |
| 3 | $23.27 | 22,645 | $527K | 22.9% |
| 4 | $23.27 | 22,645 | $527K | 22.9% |
| Total | $23.03 avg | 100,000 | $2.3M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |